WO2007123044A1 - 甘草ポリフェノール製剤 - Google Patents
甘草ポリフェノール製剤 Download PDFInfo
- Publication number
- WO2007123044A1 WO2007123044A1 PCT/JP2007/058078 JP2007058078W WO2007123044A1 WO 2007123044 A1 WO2007123044 A1 WO 2007123044A1 JP 2007058078 W JP2007058078 W JP 2007058078W WO 2007123044 A1 WO2007123044 A1 WO 2007123044A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- licorice
- fatty acid
- weight
- water
- preparation
- Prior art date
Links
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 title claims abstract description 161
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 title claims abstract description 161
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 title claims abstract description 161
- 229940010454 licorice Drugs 0.000 title claims abstract description 161
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 86
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 80
- 244000303040 Glycyrrhiza glabra Species 0.000 title description 8
- 241000202807 Glycyrrhiza Species 0.000 claims abstract description 158
- 239000000203 mixture Substances 0.000 claims abstract description 87
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 62
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 42
- -1 fatty acid ester Chemical class 0.000 claims abstract description 35
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 31
- 239000000194 fatty acid Substances 0.000 claims abstract description 31
- 229930195729 fatty acid Natural products 0.000 claims abstract description 31
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract description 21
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 36
- 235000013305 food Nutrition 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 14
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 10
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 8
- 229920005862 polyol Polymers 0.000 claims description 8
- 150000003077 polyols Chemical class 0.000 claims description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- 239000005639 Lauric acid Substances 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 abstract description 4
- 229940069445 licorice extract Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000011850 water-based material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 239000007764 o/w emulsion Substances 0.000 description 19
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 239000002253 acid Substances 0.000 description 16
- 239000000839 emulsion Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 8
- 229920000053 polysorbate 80 Polymers 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000004530 micro-emulsion Substances 0.000 description 6
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 6
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 3
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 3
- CUFAXDWQDQQKFF-DEOSSOPVSA-N Glabrol Chemical compound C1=C(O)C(CC=C(C)C)=CC([C@H]2OC3=C(CC=C(C)C)C(O)=CC=C3C(=O)C2)=C1 CUFAXDWQDQQKFF-DEOSSOPVSA-N 0.000 description 3
- CUFAXDWQDQQKFF-XMMPIXPASA-N Glabrol Natural products O=C1c2c(c(C/C=C(\C)/C)c(O)cc2)O[C@@H](c2cc(C/C=C(\C)/C)c(O)cc2)C1 CUFAXDWQDQQKFF-XMMPIXPASA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 150000004671 saturated fatty acids Chemical group 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- PDKHNRSRVURSHL-UHFFFAOYSA-N 3-(2,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one Chemical compound O=C1C=2C(O)=C(CC=C(C)C)C(OC)=CC=2OCC1C1=CC=C(O)C=C1O PDKHNRSRVURSHL-UHFFFAOYSA-N 0.000 description 2
- QHJJASRUTXHRAL-UHFFFAOYSA-N 4-[5,7-dimethoxy-6-(3-methylbut-2-enyl)-2h-chromen-3-yl]benzene-1,3-diol Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(OC)=CC=2OCC=1C1=CC=C(O)C=C1O QHJJASRUTXHRAL-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- DPLWUTYEBRKBLI-UHFFFAOYSA-N Glyurallin B Chemical compound OC1=C(O)C(CC=C(C)C)=CC(C=2C(C3=C(O)C=C(O)C(CC=C(C)C)=C3OC=2)=O)=C1 DPLWUTYEBRKBLI-UHFFFAOYSA-N 0.000 description 2
- PGCKDCPTJAQQSQ-UHFFFAOYSA-N Isolicoflavonol Chemical compound C1=C(O)C(CC=C(C)C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 PGCKDCPTJAQQSQ-UHFFFAOYSA-N 0.000 description 2
- YGCCASGFIOIXIN-UHFFFAOYSA-N Lupiwighteone Chemical compound CC(C)=CCC1=C(O)C=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 YGCCASGFIOIXIN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- FWWGXZYUURXJLK-UHFFFAOYSA-N glycyrin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(OC)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O FWWGXZYUURXJLK-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- UACNRZUVCUEUPY-UHFFFAOYSA-N 4-[7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-2h-chromen-3-yl]benzene-1,3-diol Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC=1C1=CC=C(O)C=C1O UACNRZUVCUEUPY-UHFFFAOYSA-N 0.000 description 1
- OTJMSWBNEUNNEW-UHFFFAOYSA-N 7-hydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)-5-methoxy-2,3-dihydrochromen-4-one Chemical compound O1C(C)(C)C=CC2=CC(C3COC=4C=C(O)C=C(C=4C3=O)OC)=CC(O)=C21 OTJMSWBNEUNNEW-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FZKIFWZDWHZTMM-UHFFFAOYSA-N Dehydroglyasperin C Natural products COc1c(CC=C(C)C)c(O)cc2OCC(=Cc12)c3cc(O)cc(O)c3 FZKIFWZDWHZTMM-UHFFFAOYSA-N 0.000 description 1
- 240000002635 Dendrocalamus asper Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- SQOFOICCLANSLR-UHFFFAOYSA-N Echinatin Natural products CC(C)C(O)(C(C)O)C(=O)OCC1=CCN2CCC(O)C12C SQOFOICCLANSLR-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- NBDITDYZVYHVMT-INIZCTEOSA-N Glyasperin D Natural products COc1cc2OC[C@H](C(=O)c2c(OC)c1CC=C(C)C)c3ccc(O)cc3O NBDITDYZVYHVMT-INIZCTEOSA-N 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- OTJMSWBNEUNNEW-AWEZNQCLSA-N Glycyrrhisoflavanone Natural products O(C)c1c2C(=O)[C@H](c3cc(O)c4OC(C)(C)C=Cc4c3)COc2cc(O)c1 OTJMSWBNEUNNEW-AWEZNQCLSA-N 0.000 description 1
- 241000126700 Glycyrrhiza eurycarpa Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- MIWDWORIJPQZQV-UHFFFAOYSA-N Licocoumarone Natural products CC(=CCc1c(O)cc2oc(cc2c1O)c3ccc(O)cc3O)C MIWDWORIJPQZQV-UHFFFAOYSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- ZKEHDQGXEYXKFI-UHFFFAOYSA-N Lupiwighteone hydrate Natural products CC(C)(O)CCC1=C(O)C=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 ZKEHDQGXEYXKFI-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- GENFCVZSDBHEJM-UHFFFAOYSA-N Semilicoisoflavone B Natural products CC1(C)Oc2c(O)cc(cc2C=C1)C3COc4cc(O)cc(O)c4C3=O GENFCVZSDBHEJM-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- QJKMIJNRNRLQSS-WEVVVXLNSA-N echinatin Chemical compound COC1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1 QJKMIJNRNRLQSS-WEVVVXLNSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- VPLBRJKVBQFZMH-UHFFFAOYSA-N gancaonin I Natural products COc1cc2oc(cc2c(O)c1CC=C(C)C)c3ccc(O)cc3O VPLBRJKVBQFZMH-UHFFFAOYSA-N 0.000 description 1
- DKVBYQAVNNRVNN-UHFFFAOYSA-N gancaonin I Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(OC)=CC=2OC=1C1=CC=C(O)C=C1O DKVBYQAVNNRVNN-UHFFFAOYSA-N 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- DDMAUIOCNQXFHL-AWEZNQCLSA-N glyasperin D Chemical compound C1([C@@H]2COC=3C=C(C(=C(OC)C=3C2)CC=C(C)C)OC)=CC=C(O)C=C1O DDMAUIOCNQXFHL-AWEZNQCLSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- NZYSZZDSYIBYLC-UHFFFAOYSA-N glycycoumarin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O NZYSZZDSYIBYLC-UHFFFAOYSA-N 0.000 description 1
- NPQWZAAWZLVQIZ-UHFFFAOYSA-N glycycoumarin Natural products COc1cc2OC(=O)C(=Cc2c(O)c1CC=C(C)C)c3ccc(O)cc3O NPQWZAAWZLVQIZ-UHFFFAOYSA-N 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- SFVVQRJOGUKCEG-UHFFFAOYSA-N isoechinatine Natural products C1CC(O)C2C(COC(=O)C(O)(C(C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-UHFFFAOYSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- CNPMAFLUEHEXRE-UHFFFAOYSA-N licocoumarone Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OC=1C1=CC=C(O)C=C1O CNPMAFLUEHEXRE-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- QJKMIJNRNRLQSS-UHFFFAOYSA-N loureirin C Natural products COC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1 QJKMIJNRNRLQSS-UHFFFAOYSA-N 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- LWZACZCRAUQSLH-UHFFFAOYSA-N semilicoisoflavone B Chemical compound OC1=CC(O)=C2C(=O)C(C3=CC(O)=C4OC(C=CC4=C3)(C)C)=COC2=C1 LWZACZCRAUQSLH-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/01—Other fatty acid esters, e.g. phosphatides
- A23D7/011—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Definitions
- the present invention relates to a licorice polyphenol preparation that can be used in foods and beverages such as health foods and health functional foods (foods for specified health use, functional foods for nutrition), pharmaceuticals, quasi drugs, and cosmetics About.
- Licorice is known as a herbal medicine, and glycyrrhizin (daricylic acid), the main component of its water extract, has a wide range of pharmacological effects such as anti-inflammatory, anti-tumor and anti-allergic effects. It has been used for foods, pharmaceuticals, cosmetics, etc. It is also used as a sweetener because it is about 200 times sweeter than sucrose.
- licorice hydrophobic components extracted from licorice or licorice water extraction residues with organic solvents etc. have antioxidant, antibacterial, enzyme inhibitory, antitumor, antiallergic, antiviral, etc. It has been confirmed that it exhibits many useful effects.
- this licorice hydrophobic component hardly dissolves in water and general oils, and it is difficult to use because it may be unstable, such as being easily consolidated and colored with an organic solvent extract.
- Patent Document 2 discloses that a licorice hydrophobic flavonoid dissolved in a medium-chain fatty acid triglyceride is prepared into an oil-in-water emulsion in the presence of an emulsifier. It is intended, not for transparency or acid resistance.
- Patent Document 3 proposes a composition containing a licorice oily extract and a polyglycerin laurate.
- Patent Document 4 discloses concentrated milk using glyceryl fatty acid ester as an emulsifier in a licorice hydrophobic component-containing oil and fat composition. This concentrated milk is not transparent. Therefore, it is considered unsuitable for applications that require transparency.
- microemulsion pre-concentrate in this technology is a system in which a lipophilic substance is dissolved in an emulsifier to form microemulsion.
- a lipophilic substance is dissolved in an emulsifier to form microemulsion.
- the microemulsion of submicron order is reduced. It is a self-emulsifying formulation that forms.
- Patent Document 1 WO03 / 084556
- Patent Document 2 JP-A-2-204417
- Patent Document 3 Japanese Patent Laid-Open No. 2003-176233
- Patent Document 4 WO2005Z011672
- Patent Document 5 EP1249230
- the conventional licorice hydrophobic component-containing composition lacks dispersibility and transparency, and has insufficient heat resistance and acid resistance when intended for use in an aqueous object. For example, its application has its limits.
- a high-pressure treatment is necessary to impart transparency, and the process is complicated. It was also divided that there was a problem of being.
- An object of the present invention is to provide a licorice polyphenol preparation which has high bioavailability and can be obtained by a simple process.
- Another object of the present invention is to maintain a high level of clarity without impairing the original properties of the target object even when the product is added to the aqueous target object.
- the present inventors can easily produce a stable licorice polyol formulation by combining specific components, and the resulting formulation can be brought into contact with an aqueous medium. It has been found that it is a self-emulsifying preparation that forms microemulsion, and that it has the effect of preventing licorice hydrophobic components from insoluble wrinkles, and the present invention has been completed. That is, the present invention is as follows.
- the total weight of the licorice hydrophobic extract based on licorice polyphenol, medium-chain fatty acid triglyceride and polyoxyethylene sorbitan fatty acid ester, and the total weight of the licorice hydrophobic extract and medium-chain fatty acid triglyceride A licorice polyphenol formulation in which the weight ratio of polyoxyethylene sorbitan fatty acid ester is in the range of 1: 1 to L: 10.
- the fatty acid residue power of polyoxyethylene sorbitan fatty acid ester The licorice polyphenol preparation according to (1) or (2), which is at least one selected from the group consisting of lauric acid, stearic acid and oleic acid power.
- a licorice polyphenol preparation which is stable at a high concentration can be provided.
- the preparation of the present invention can be made into a highly transparent emulsion composition simply by mixing with water. Obedience Therefore, by using the present invention, it is possible to produce an aqueous object having high bioavailability and capable of efficiently supplying licorice polyphenol components.
- the emulsion composition obtained by the preparation of the present invention is excellent in acid resistance and heat resistance, and can be applied to various applications.
- the licorice polyphenol preparation of the present invention does not require high-pressure treatment, and can be prepared as an emulsion composition with high transparency just by mixing with water.
- the licorice polyphenol preparation of the present invention comprises a licorice hydrophobic extract based on licorice polyphenol, a medium-chain fatty acid triglyceride, and a polyoxyethylene sorbitan fatty acid ester, and the licorice in the preparation.
- the formulation is characterized in that the specific weight of the total weight of the hydrophobic extract and medium chain fatty acid triglyceride and the weight of the polyoxyethylene sorbitan fatty acid ester is in the range of 1: 1 to 1:10.
- the licorice from which the licorice hydrophobic extract is derived is not particularly limited as long as it is a plant belonging to the genus Glycyrrhiza, but, for example, Dali Killly the Grabra (G. glabra, G. uralensis, G. inflata, G. eurycarpa, G. aspera, etc., preferably G. glabra, G. uralensi s, G. inflata, particularly preferably G. glabra.
- the licorice hydrophobic extract used in the present invention is an extract of licorice based on licorice polyphenol.
- the term “main component” as used herein means, for example, that 50% by weight or more, preferably 60% by weight or more, more preferably 80% by weight or more in the hydrophobic extract of licorice is a phenol component.
- the method for obtaining the licorice hydrophobic extract is not particularly limited, and a known method can be used. For example, it can be obtained by extraction from the above licorice or its powder or the residue of the water extract thereof with an organic solvent (eg, ethanol, acetone, ethyl acetate, etc.).
- an organic solvent eg, ethanol, acetone, ethyl acetate, etc.
- medium chain fatty acid triglyceride is used as an oil and fat component, so that licorice can be obtained using the method described in WO03 / 084556 (Patent Document 1) or WO2005Z011672 (Patent Document 4). It is also preferred to obtain the hydrophobic extract as a solution of medium chain fatty acid triglycerides. Concrete In the licorice hydrophobic extract, the rhizome part of licorice is extracted with ethanol, medium chain fatty acid triglycerides are added to the resulting licorice hydrophobic extract-containing ethanol solution, and then ethanol is removed. A chain fatty acid triglyceride solution may be used.
- the licorice polyphenol preparation of the present invention can be obtained by adding and mixing a predetermined amount of polyoxyethylene sorbitan fatty acid ester to the medium chain fatty acid triglyceride solution of the obtained licorice hydrophobic extract.
- the hydrophobic extract of licorice used as the raw material of the polyphenol preparation of the present invention includes glycycoumarin, glycyrol, glycyrin, and liquiritigenin as licorice polyphenol components.
- glabrizine glabrene, glabrol
- all of the above-mentioned five components which preferably contain at least one of 3'-hydroxy 4'-O methyl grabridine and 4 'O methyl grabridine, are included.
- the medium chain fatty acid triglyceride used in the present invention is not particularly limited as long as it also has a fatty acid power having 6 to 12 carbon atoms, but is preferably a saturated fatty acid having 8 or 10 carbon atoms, most preferably. Is composed mainly of triglycerides composed of saturated fatty acids with 8 carbon atoms.
- polyoxyethylene sorbitan fatty acid ester is used as an emulsifier.
- Polyoxyethylene sorbitan fatty acid ester is obtained by adding ethylene oxide to sorbitan fatty acid ester. It is an emulsifier having higher hydrophilicity than a fatty acid ester.
- the fatty acid residue of the polyoxyethylene sorbitan fatty acid ester is not particularly limited, but a saturated or unsaturated fatty acid having 14 to 18 carbon atoms such as lauric acid, stearic acid, or oleic acid is used as a fatty acid residue.
- the polyoxyethylene sorbitan fatty acid ester possessed as is preferably used.
- the degree of esterification of these fatty acid residues is not particularly limited, but is preferably monoesterified. Of course, a mixture thereof may be used.
- Polyoxyethylene sorbitan fatty acid ester used in the present invention preferably has high hydrophilicity.
- the ratio between the weight (content) of the polyoxyethylene sorbitan fatty acid ester in the preparation and the total weight (total content) of the licorice hydrophobic extract and medium-chain fatty acid triglycerides is in the range of 1: 1 to 1:10.
- the polyoxyethylene sorbitan fatty acid ester must be used in the range of 100 to 1000 parts by weight with respect to the total amount of licorice hydrophobic extract and medium chain fatty acid triglyceride being 100 parts by weight.
- the range is 500 parts by weight. If the amount of polyoxyethylene sorbitan fatty acid ester added is less than 100 parts by weight relative to 100 parts by weight of the total amount of licorice hydrophobic extract and medium chain fatty acid triglyceride, a stable water-soluble composition cannot be obtained. If it exceeds 1000 parts by weight, it will not dissolve properly when added to water-based objects.
- the ratio of licorice polyphenol to medium-chain fatty acid triglycerides in the preparation is preferably in the range of 1 to 50% by weight.
- the quantification of the licorice polyphenol component mentioned here can be determined as a value converted to grabrizine, for example, by the method described in the examples described later.
- the fat and oil component is not particularly limited.
- the fats and oils which performed etc. or these mixed oils can be used.
- the licorice polyphenol preparation of the present invention may contain other oil-soluble physiologically active substances.
- oil-soluble physiologically active substances include fat-soluble vitamins such as vitamins A, D, E, K, and salmon, coenzyme Q (ubiquinone or ubiquinol), and lipoic acid.
- coenzyme Q ubiquinone or ubiquinol
- lipoic acid it is preferable to contain Coenzyme Q, particularly Coenzyme Q10.
- Coenzyme Q10 is localized in mitochondria, lysosomes, Golgi, microsomes, peroxinome, or cell membranes, and as a component of the electron transport system, it activates ATP production, in vivo antioxidant action, and membrane stability.
- the licorice polyphenol preparation of the present invention not only can stably formulate hydrophobic extracts of licorice, but also can stably formulate oil-soluble bioactive ingredients such as Coenzyme Q10, which can be mixed with water. If it can be made into an aqueous solution (microemulsion) with high transparency, it is excellent in this respect.
- the amount of the oil-soluble physiologically active substance that can be contained in the licorice polyphenol preparation of the present invention is not particularly limited, and is appropriately selected within a range that does not impair the stability of the preparation and emulsification when mixed with water.
- the weight ratio of the content of licorice polyphenol to the content of Coenzyme Q10 is preferably selected in the range of 1:10 to LO: l from the viewpoint of the stability and efficacy of the preparation.
- oil-soluble ingredients such as oil-soluble fragrances, essential oils, coloring agents, antioxidants, and specific gravity adjusting agents can be contained in the licorice polyphenol preparation of the present application.
- the licorice polyol formulation of the present invention is a self-emulsifying formulation, and can be easily mixed with an aqueous component such as water to easily produce an emulsion composition containing licorice polyol (for example, in water Oil type emulsion composition) can be prepared.
- an aqueous component such as water to easily produce an emulsion composition containing licorice polyol (for example, in water Oil type emulsion composition) can be prepared.
- an aqueous component used at this time water itself or an aqueous solution in which a water-soluble component is dissolved in water is preferably used. It may also be a mixture of water and a polyhydric alcohol (polyhydric alcohol aqueous solution).
- the polyhydric alcohol in this case include sugars such as liquid sugar and sugar alcohols such as glycerin and sorbitol.
- water-soluble vitamins such as vitamin C
- water-soluble ingredients such as organic acids, amino acids, L-strength routine, and various salts
- the ratio of the licorice polyphenol preparation and the aqueous component in preparing the oil-in-water emulsion composition is not particularly limited, but is preferably in the range of 1: 0.1 to 1: 1000 by weight.
- the licorice polyphenol preparation of the present invention becomes an emulsified composition simply by mixing with an aqueous component such as water with a stirrer or stirrer.
- an aqueous component such as water
- stirrer or stirrer For stabilization, high-pressure emulsification or homogenization treatment may be performed.
- the emulsion composition of the present invention is adjusted so that the median diameter of the milky wrinkle particles is preferably lOOnm or less, more preferably 80nm or less, and still more preferably 50nm or less.
- the median diameter of the emulsified particles of the oil-in-water emulsion composition of the present invention is usually about lOnm or more.
- the median diameter of the emulsified particles is used as an index indicating the stability of emulsification.
- the median diameter of the emulsified particles of the emulsion having a uniform dispersion state is approximately 100 m (10 OOOOnm) or less.
- the so-called ordinary emulsion is a cloudy solution having a median diameter in the range of 0.1 to 100 m (100 to 100,000 nm).
- the median diameter is less than lOOnm, even an emulsion becomes an almost transparent solution, and when it is less than 50 nm, it becomes a solution having very high V transparency.
- the emulsified composition of the present invention is added to sugars such as dextrin and lactose, sugar alcohols such as erythritol, excipients such as gum arabic and gati gum, and then a known method such as spray drying or freeze drying. It is also possible to remove moisture by a method to obtain a dry powder.
- the amount of the excipient is not particularly limited, but the weight ratio of the licorice polyphenol preparation to the excipient is preferably in the range of 1: 0.2 to 1: 100.
- the obtained dry powder is easily dissolved in water to easily form an aqueous solution (emulsion composition) containing licorice polyphenol. It can be done.
- the licorice polyol formulation of the present invention or an emulsified composition or a dry powder obtained therefrom, is used as it is or as a composition containing it, such as foods, pharmaceuticals, quasi drugs, cosmetics, and animal feeds. Can be used for
- the licorice polyol formulation of the present invention or an emulsified composition or a dry powder obtained therefrom is taken as a pharmaceutical or food, it is filled in a capsule as it is or mixed with a known carrier, You can also Furthermore, when used as food, it can be added to food as it is or dissolved in water to prepare confectionery such as chewing gum, chocolate, candy, jelly, biscuits, crackers, ice cream, ice confectionery.
- Frozen confectionery such as udon, Chinese rice cake, spaghetti, instant rice cakes, kneaded products such as rice cakes, bamboo rings, half pieces, seasonings such as dressing, mayonnaise, sauces, bread, ham, soup, various retort foods
- it can be used for various frozen foods, and can also be used for pet food and livestock feed.
- beverages such as soft drinks, energy drinks and beauty drinks.
- the foods and beverages in the present invention include health foods, health functional foods (specific health foods, nutritional functional foods) and the like.
- the amount added when the licorice polyol formulation of the present invention, or the emulsified composition or dry powder obtained therefrom is added to foods is not particularly limited.
- one packaging unit For example, it is preferable that the content of licorice polyphenol per 1) is about 10 to 200 mg, or the content of grabridine is about 1 to 20 mg.
- LB-550 (manufactured by HORIBA, Ltd.) was used for measurement.
- Rhizome ofAN licorice G. glabra 1.
- OL 45 ° C, 2 hours, 2 times followed by concentration under reduced pressure gave 0.45L of concentrate . Then this concentrate.
- activated carbon treatment was performed to obtain 123.6 g of ethanol solution containing licorice hydrophobic extract (containing 24.8 g of licorice hydrophobic extract).
- the licorice hydrophobic extract-containing medium chain fatty acid triglyceride solution lg was dissolved in methanol for HPLC to adjust the total volume to 100 ml.
- the ratio of B is kept constant at 50% until 20 minutes after the start of analysis, and is increased at a constant ratio so that it becomes 80% after 75 minutes and after 75 minutes.
- each medium-chain fatty acid triglyceride solution lg containing licorice hydrophobic extract is as follows: grabrene (4.4 mg), grabridine (30. Omg), grabrol (6.0 mg), 4, 1 O methinoreg grabridine (5.2 mg).
- Polyoxyethylene sorbitan monooleate (Sorgen TW80) with respect to 10% by weight of the licorice hydrophobic extract-containing medium chain fatty acid triglyceride solution obtained in Preparation Example 2 was added and mixed to prepare a licorice polyphenol preparation.
- the obtained licorice polyphenol preparation was press-fitted into the gelatin film using a rotary soft capsule production apparatus to obtain a soft capsule having an internal volume of 350 mg.
- Each capsule contained 0.3 mg, 1.8 mg, 0.4 mg, and 0.3 mg of glabrene, grabridine, glabrol, and 4 ′ O methylgrabridine (total amount: 2.8 mg, content: 0. 8% by weight).
- Licorice polyphenol-containing oil-in-water emulsified yarn and composition 2.4 parts by weight
- an aqueous solution containing licorice polyphenol As an evaluation of acid and heat stability, an aqueous solution containing licorice polyphenol When the median diameter of the water-soluble composition before and after heating at 75 ° C for 15 minutes was measured using LB-550, the pH3 water was added to 50 parts by weight with respect to parts by weight. Before heating, it was 66.5 mm, and after calorific heat was 139.6 nm.
- Table 2 shows the results obtained by preparing a phenol-containing oil-in-water emulsion composition and measuring the particle size of the obtained licorice polyphenol-containing oil-in-water emulsion composition.
- Tsuzuic ⁇ Te have want emulsified broken separate upon addition of the oil-in-water emulsion composition of the acid and was Utoshi Gyoo stability evaluation force water and Kuen acid aqueous solution to heat (P H3 water), the emulsion particle size The measurement was powerful.
- licorice hydrophobic extract-containing medium-chain fatty acid triglyceride solution from Preparation Example 2 5 parts by weight of a licorice hydrophobic extract-containing medium-chain fatty acid triglyceride solution from Preparation Example 2 and 10 parts by weight of decadari serine monolaurate (manufactured by Sakamoto Yakuhin Kogyo Co., Ltd .; ML-750) are heated to 60 ° C to complete Dissolved in.
- the resulting licorice polyphenol solution was added to 85 parts by weight of water at 60 ° C and mixed vigorously with a magnetic stirrer.
- Nanomizer Ichigo manufactured by Yoshida Kikai Kogyo Co., Ltd.
- treatment was carried out 10 times at an emulsification pressure lOOMPa to prepare a licorice polyphenol-containing oil-in-water emulsion composition.
- Table 3 summarizes the results of measuring the particle size of the resulting licorice polyphenol-containing oil-in-water emulsion composition and evaluating the stability against acid and heat.
- a dry powder of the licorice polyphenol-containing emulsion composition was prepared according to the following formulation. To 180 parts by weight of water, 4 parts by weight of a licorice polyphenol preparation prepared in the same manner as in Example 1 and 16 parts by weight of dextrin (Matsuya Igaku Co., Ltd .; Pinedetas # 2) were added and stirred. Subsequently, the water was removed by spray drying (manufactured by Nippon Büch Co., Ltd.) to prepare a dry powder of the licorice polyphenol-containing emulsion composition. The obtained powder was easily dissolved when mixed with water, and became a highly transparent emulsified aqueous solution.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT07741514T ATE550028T1 (de) | 2006-04-17 | 2007-04-12 | Süssholzwurzel-polyphenol-zubereitung |
US12/297,354 US8906424B2 (en) | 2006-04-17 | 2007-04-12 | Licorice polyphenol preparation |
KR1020087027902A KR101449764B1 (ko) | 2006-04-17 | 2007-04-12 | 감초 폴리페놀 제제 |
EP07741514A EP2018869B1 (en) | 2006-04-17 | 2007-04-12 | Licorice polyphenol preparation |
MX2008013284A MX2008013284A (es) | 2006-04-17 | 2007-04-12 | Preparacion de polifenol regaliz. |
JP2008512082A JP5070203B2 (ja) | 2006-04-17 | 2007-04-12 | 甘草ポリフェノール製剤 |
CA002649514A CA2649514A1 (en) | 2006-04-17 | 2007-04-12 | Licorice polyphenol preparation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006112961 | 2006-04-17 | ||
JP2006-112961 | 2006-04-17 | ||
JP2006198908 | 2006-07-21 | ||
JP2006-198908 | 2006-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007123044A1 true WO2007123044A1 (ja) | 2007-11-01 |
Family
ID=38624948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/058078 WO2007123044A1 (ja) | 2006-04-17 | 2007-04-12 | 甘草ポリフェノール製剤 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8906424B2 (ja) |
EP (1) | EP2018869B1 (ja) |
JP (1) | JP5070203B2 (ja) |
KR (1) | KR101449764B1 (ja) |
AT (1) | ATE550028T1 (ja) |
CA (1) | CA2649514A1 (ja) |
MX (1) | MX2008013284A (ja) |
TW (1) | TW200808333A (ja) |
WO (1) | WO2007123044A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
JP2016130220A (ja) * | 2015-01-13 | 2016-07-21 | 日本メナード化粧品株式会社 | 透明化粧料 |
US9919017B2 (en) | 2011-02-01 | 2018-03-20 | Kaneka Corporation | Biologically active substance-containing water-solubilizing preparation and method for producing the same |
JP2018100247A (ja) * | 2016-12-21 | 2018-06-28 | 松浦薬業株式会社 | デキストリン製剤 |
WO2022030443A1 (ja) * | 2020-08-07 | 2022-02-10 | キッコーマン株式会社 | 飲食品 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2069699A2 (en) * | 2006-10-03 | 2009-06-17 | Wyeth | Lyophilization methods and apparatuses |
ES2414158T3 (es) | 2008-10-20 | 2013-07-18 | Unilever Nv | Una composición antimicrobiana |
PL2480090T3 (pl) | 2009-09-24 | 2014-04-30 | Unilever Nv | Środek dezynfekujący zawierający eugenol, terpineol oraz tymol |
CN103354741B (zh) | 2010-12-07 | 2016-01-13 | 荷兰联合利华有限公司 | 口腔护理组合物 |
CN102106818B (zh) * | 2010-12-14 | 2012-09-05 | 石河子大学医学院第一附属医院 | 异甘草素微乳剂组合物 |
KR101293274B1 (ko) * | 2011-02-11 | 2013-08-02 | 서울대학교산학협력단 | 데하이드로글리아스페린 디를 유효성분으로 포함하는 것을 특징으로 하는 피부질환 예방 또는 치료용 조성물 |
EP2773315B1 (en) | 2011-11-03 | 2015-07-08 | Unilever N.V. | A personal cleaning composition |
CN103945693B (zh) * | 2011-11-25 | 2016-08-17 | 荷兰联合利华有限公司 | 抗微生物微乳组合物 |
CN103380827B (zh) * | 2012-05-02 | 2017-10-27 | 丰益(上海)生物技术研发中心有限公司 | 一种预防肥胖性脂肪肝的油脂组合物及其制备方法 |
CN103636948A (zh) * | 2013-12-26 | 2014-03-19 | 重庆市优胜科技发展有限公司 | 甘草提取物饲料添加剂 |
US11344509B2 (en) * | 2017-07-11 | 2022-05-31 | Aquanova Ag | Solubilizate with curcumin and boswellia and xanthohumol |
FI3820527T3 (en) | 2018-07-11 | 2023-09-28 | Aquanova Ag | XANTHOHUMOL CELL BILISATE |
EP3820527B1 (de) * | 2018-07-11 | 2023-08-23 | Aquanova AG | Xanthohumol-solubilisat |
CN110079393B (zh) * | 2019-04-29 | 2021-12-28 | 亿利耐雀生物科技有限公司 | 一种爆珠精油及其制备方法和应用 |
TWI757830B (zh) * | 2020-08-14 | 2022-03-11 | 長庚醫療財團法人嘉義長庚紀念醫院 | 甘草萃取液用於製備治療聲帶閉鎖不全之藥物的用途 |
WO2023282783A1 (ru) * | 2021-07-09 | 2023-01-12 | Акционерное Общество "Акванова Рус" | Мицеллированный раствор активного компонента на основе экстракта лакрицы, способ его получения и применения |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02204417A (ja) | 1989-02-02 | 1990-08-14 | Maruzen Kasei Co Ltd | 甘草疎水性フラボノイド製剤 |
JPH06107532A (ja) * | 1992-09-28 | 1994-04-19 | Kao Corp | 美白化粧料 |
JPH06199646A (ja) * | 1992-12-28 | 1994-07-19 | Kao Corp | 美白化粧料 |
JP2000212060A (ja) * | 1999-01-22 | 2000-08-02 | Naris Cosmetics Co Ltd | 化粧料 |
EP1249230A1 (de) | 2001-04-12 | 2002-10-16 | Vesifact Ag | Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen |
JP2003073219A (ja) * | 2001-08-30 | 2003-03-12 | Nikko Seiyaku Kk | ビタミンc誘導体と油溶性甘草エキスを配合した外用剤 |
JP2003176233A (ja) | 2001-12-12 | 2003-06-24 | Tokyo Food Techno Kk | 水系対象物への甘草油性抽出物可溶化方法 |
WO2003084556A1 (fr) | 2002-04-04 | 2003-10-16 | Kaneka Corporation | Procede de fabrication de composition lipidique contenant des composants hydrophobes de glycyrrhiza |
WO2005011672A1 (ja) | 2003-07-31 | 2005-02-10 | Kaneka Corporation | 生活習慣病予防・改善用の油脂加工組成物 |
WO2005110400A1 (ja) * | 2004-05-13 | 2005-11-24 | Kaneka Corporation | リパーゼ阻害剤、コレステロールエステラーゼ阻害剤、中性脂肪吸収抑制剤、コレステロール吸収抑制剤及びコレステロールエステル吸収抑制剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980031601A (ko) * | 1996-10-31 | 1998-07-25 | 김윤 | 난용성 약물의 가용화 방법 |
US5744187A (en) * | 1996-12-16 | 1998-04-28 | Gaynor; Mitchel L. | Nutritional powder composition |
-
2007
- 2007-04-11 TW TW096112723A patent/TW200808333A/zh unknown
- 2007-04-12 AT AT07741514T patent/ATE550028T1/de active
- 2007-04-12 MX MX2008013284A patent/MX2008013284A/es active IP Right Grant
- 2007-04-12 CA CA002649514A patent/CA2649514A1/en not_active Abandoned
- 2007-04-12 JP JP2008512082A patent/JP5070203B2/ja not_active Expired - Fee Related
- 2007-04-12 EP EP07741514A patent/EP2018869B1/en not_active Not-in-force
- 2007-04-12 KR KR1020087027902A patent/KR101449764B1/ko active IP Right Grant
- 2007-04-12 WO PCT/JP2007/058078 patent/WO2007123044A1/ja active Application Filing
- 2007-04-12 US US12/297,354 patent/US8906424B2/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02204417A (ja) | 1989-02-02 | 1990-08-14 | Maruzen Kasei Co Ltd | 甘草疎水性フラボノイド製剤 |
JPH06107532A (ja) * | 1992-09-28 | 1994-04-19 | Kao Corp | 美白化粧料 |
JPH06199646A (ja) * | 1992-12-28 | 1994-07-19 | Kao Corp | 美白化粧料 |
JP2000212060A (ja) * | 1999-01-22 | 2000-08-02 | Naris Cosmetics Co Ltd | 化粧料 |
EP1249230A1 (de) | 2001-04-12 | 2002-10-16 | Vesifact Ag | Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen |
JP2003073219A (ja) * | 2001-08-30 | 2003-03-12 | Nikko Seiyaku Kk | ビタミンc誘導体と油溶性甘草エキスを配合した外用剤 |
JP2003176233A (ja) | 2001-12-12 | 2003-06-24 | Tokyo Food Techno Kk | 水系対象物への甘草油性抽出物可溶化方法 |
WO2003084556A1 (fr) | 2002-04-04 | 2003-10-16 | Kaneka Corporation | Procede de fabrication de composition lipidique contenant des composants hydrophobes de glycyrrhiza |
WO2005011672A1 (ja) | 2003-07-31 | 2005-02-10 | Kaneka Corporation | 生活習慣病予防・改善用の油脂加工組成物 |
WO2005110400A1 (ja) * | 2004-05-13 | 2005-11-24 | Kaneka Corporation | リパーゼ阻害剤、コレステロールエステラーゼ阻害剤、中性脂肪吸収抑制剤、コレステロール吸収抑制剤及びコレステロールエステル吸収抑制剤 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
US9919017B2 (en) | 2011-02-01 | 2018-03-20 | Kaneka Corporation | Biologically active substance-containing water-solubilizing preparation and method for producing the same |
JP2016130220A (ja) * | 2015-01-13 | 2016-07-21 | 日本メナード化粧品株式会社 | 透明化粧料 |
JP2018100247A (ja) * | 2016-12-21 | 2018-06-28 | 松浦薬業株式会社 | デキストリン製剤 |
WO2022030443A1 (ja) * | 2020-08-07 | 2022-02-10 | キッコーマン株式会社 | 飲食品 |
Also Published As
Publication number | Publication date |
---|---|
ATE550028T1 (de) | 2012-04-15 |
CA2649514A1 (en) | 2007-11-01 |
US20090087419A1 (en) | 2009-04-02 |
EP2018869B1 (en) | 2012-03-21 |
EP2018869A4 (en) | 2009-12-16 |
KR101449764B1 (ko) | 2014-10-13 |
JPWO2007123044A1 (ja) | 2009-09-03 |
MX2008013284A (es) | 2009-01-14 |
US8906424B2 (en) | 2014-12-09 |
EP2018869A1 (en) | 2009-01-28 |
TW200808333A (en) | 2008-02-16 |
KR20090009242A (ko) | 2009-01-22 |
JP5070203B2 (ja) | 2012-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5070203B2 (ja) | 甘草ポリフェノール製剤 | |
WO2007097412A1 (ja) | 甘草ポリフェノール含有水中油型乳化組成物 | |
JP5343002B2 (ja) | 生理活性物質含有組成物 | |
US6190680B1 (en) | Oily composition and process for producing the same | |
JP4685355B2 (ja) | 甘草疎水性成分含有油脂組成物の製造方法 | |
JP5377304B2 (ja) | 補酵素q10含有組成物 | |
WO2006035900A1 (ja) | コエンザイムq10含有乳化組成物 | |
KR101061679B1 (ko) | 코엔자임 q10 을 함유하는 수용성 조성물 | |
KR20200034789A (ko) | 수중유형 유화 조성물과, 이것을 포함하는 식품 및 음료 | |
JP5199665B2 (ja) | コエンザイムq10含有水溶性組成物及びその製法 | |
Kumar et al. | Scope of nanotechnology in nutraceuticals | |
EP3762006B1 (en) | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents | |
JP2000157168A (ja) | 油性組成物及びその製造方法 | |
KR20160134375A (ko) | 인삼 씨 오일을 함유하는 수용성 조성물 | |
JP2017014125A (ja) | ソフトカプセル用アントシアニン含有組成物及びソフトカプセル剤 | |
WO2020196557A1 (ja) | 乳化組成物及びこれを含む飲料 | |
ES2787229T3 (es) | Composición que contiene coenzima Q10 | |
JP2000024482A (ja) | 油性組成物を含有した乳化組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07741514 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008512082 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12297354 Country of ref document: US Ref document number: 2649514 Country of ref document: CA Ref document number: MX/A/2008/013284 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007741514 Country of ref document: EP |